Pharmacodynamics of ranolazine in patients with angina pectoris and myocardial ischaemia
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2012
Price : $35 *
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris; Myocardial ischaemia
- Focus Pharmacodynamics
- 13 Sep 2012 New trial record
- 29 Aug 2012 Primary endpoint 'Coronary-flow-reserve' has been met according to results presented at the ESC Congress 2012.
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.